Shares of Halozyme Therapeutics, Inc. (Nasdaq: HALO) are seeing upside action today after analysts at William Blair initiated coverage on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE